Glutathione and adaptive immune responses against mycobacterium tuberculosis infection in healthy and HIV infected individuals

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Guerra, Carlos ^a   Morris, Devin ^a   Sipin, Andrea ^b   Kung, Steven ^b   Franklin, Mesharee ^a   Gray, Dennis ^a   Tanzil, Michelle ^a   Guilford, Frederick ^c   Khasawneh, Fadi T ^a   Venketaraman, Vishwanath ^a  

^a WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^b CALIFORNIA STATE POLYTECHNIC UNIVERSITY   (United States)

^c Your Energy Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GLUTATHIONE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 2; MALONALDEHYDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; FREE RADICAL;

ADAPTIVE IMMUNITY; ARTICLE; BACTERIAL GROWTH; CELL LEVEL; CLINICAL ARTICLE; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; GROWTH INHIBITION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE CULTURE; LYMPHOCYTE FUNCTION; MACROPHAGE; MONOCYTE; NONHUMAN; PROTEIN BLOOD LEVEL; T LYMPHOCYTE; TH1 CELL; TUBERCULOSIS; BIOSYNTHESIS; CASE CONTROL STUDY; CELL SURVIVAL; CYTOLOGY; METABOLISM; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; VIROLOGY;

CASE-CONTROL STUDIES; CELL SURVIVAL; CYTOKINES; FREE RADICALS; GLUTATHIONE; HIV INFECTIONS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2; MACROPHAGES; MONOCYTES; MYCOBACTERIUM TUBERCULOSIS; T-LYMPHOCYTES; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82555194623     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028378     Document Type: Article

References (34)

1. WHO. WHO report (2009) Global tuberculosis control. Epidemiology, strategy, eds. financing Geneva, Switzerland World Health Organization; 2009.
2. Zhang M, Gong J, Iyer DV, Jones BE, Modlin RL, et al. (1994) T cell cytokine responses in persons with tuberculosis and human immunodeficiency virus infection. J Clin Invest 94: 2435-42.
3. Buhl R, Jaffe HA, Holroyd KJ, Wells FB, Mastrangeli A, et al. (1989) Systemic glutathione deficiency in symptom-free HIV seropositive individuals. Lancet 2: 1294-8.
4. Staal F, Roederer M, Herzenberg LA, Herzenberg LA, (1990) Intracellular thiols regulate activation of nuclear factor κB and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA 87: 9943-7.
5. Staal FJ, (1998) Glutathione and HIV infection: reduced reduced, or increased oxidized? Eur J Clin Invest 28: 194-6.
6. Hirsch CS, Toossi Z, Othieno C, Johnson JL, Schwander SK, et al. (1999) Depressed T cell interferon-gamma responses in pulmonary tuberculosis: analysis of underlying mechanisms and modulation with therapy. J Infect Dis180: 2069-73.
7. Russell DG, Cardona PJ, Kim MIJ, Allain S, Altare F, (2009) Foamy macrophages and the progression of the human tuberculosis granuloma. Nature Immunology 10 (9): 943-948.
8. World Health Organization (WHO) (2003) WHO annual report on global TB control - summary. Wkly Epidemiol Rec 78: 122-8.
9. Toossi Z, Kleinhenz ME, Ellner JJ, (1986) Defective interleukin 2 production and responsiveness in human pulmonary tuberculosis. J Exp Med 163: 1162-72.
10. Huygen K, Van Vooren JP, Turneer M, Bosmans R, Dierckx P, De Bruyn J, (1988) Specific lymphoproliferation, gamma interferon production, and serum immunoglobulin G directed against a purified 32 kDa mycobacterial protein antigen (P32) in patients with active tuberculosis. Scand J Immunol 27: 187-94.
11. Torres M, Mendez-Sampeiro P, Jimenez-Zamudio L, et al. (1994) Comparison of the immune response against Mycobacterium tuberculosis antigens between a group of patients with active pulmonary tuberculosis and healthy household contacts. Clin Exp Immunol 96: 75-8.
12. Mehra S, Pahar B, Dutta NK, Conerly CN, Philippi-Falkenstein K, et al. (2010) Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 5 (8): e12266.
13. Hirsch CS, Hussain R, Toossi Z, Dawood G, Shahid F, Ellner JJ, (1996) Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production. Proc Natl Acad Sci USA.93: 3193-8.
14. Gong JH, Zhang M, Modlin RL, et al. (1996) Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression. Infect Immun 64: 913-8.
15. Hirsch CS, Ellner JJ, Blinkhorn R, Toossi Z, (1997) In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta. Proc Natl Acad Sci USA 94: 3926-31.
16. Duh E, MauryWJ, Folks TM, Fauci AS, Rabson AB, (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. Proc Natl Acad Sci USA 86: 5674-8.
17. Suthanthiran M, Anderson ME, Sharma VK, Meister A, (1990) Glutathione regulates activation-dependent DNA synthesis in highly purified normal human T lymphocytes stimulated via the CD2 and CD3 antigens. Proc Natl Acad Sci USA 87: 3343-7.
18. Venketaraman V, Dayaram YK, Amin AG, Ngo R, Green RM, Talaue MT, Mann J, Connell ND, (2003) Role of glutathione in macrophage control of Mycobacteria. Infect Immunity 71 (4): 1864-71.
19. Venketaraman V, Dayaram YK, Talaue MT, Connell ND, (2005) Glutathione and Nitrosoglutathione in macrophage defense against M. tuberculosis. Infect Immunity 73: 1886-9.
20. Dayaram YK, Talaue MT, Connell ND, Venketaraman V, (2006) Characterization of a glutathione metabolic mutant of Mycobacterium tuberculosis and its resistance to glutathione and Nitrosoglutathione. J Bacteriology 188: 1364-72.
21. Millman AC, Salman M, Dayaram YK, Connell ND, Venketaraman V, (2008) Natural killer cells, glutathione, cytokines and innate immunity against Mycobacterium tuberculosis. Journal of Interferon and Cytokine Research 28: 1-13.
22. Clerici M, Frances TH, Venzon D J, Blatt S, Hendrix CW, et al. (1993) Changes in Interleukin-2 and Interleukin-4 Production in Asymptomatic Human Immunodeficiency Virus-seropositive Individuals. J Clin Invest 91: 759-765.
23. Bahia MS, Silakari O, (2010) Tumor Necrosis Factor Alpha Converting Enzyme: An Encouraging Target for Various Inflammatory Disorders. Chemical Biology and Drug Design 75: 415-443.
24. Alfano M, Poli G, (2005) Role of cytokines and chemokines in the regulation of innate immunity and HIV infection. Molecular Immunology 42: 161-182.
25. Fernandez-Ortega C, Dubed M, Ramos T, Navea L, Alvarez G, et al. (2004) Non-induced leukocyte extract reduces HIV replication and TNF secretion. Biochemical and Biophysical Research Communications 325: 1075-1081.
26. Leghmari K, Bennasser Y, Tkaczuk J, Bahraoui E, (2008) HIV-1 Tat protein induces IL-10 production by an alternative TNF-α-independent pathway in monocytes: Role of PKC-δ and p38 MAP kinase. Cellular Immunology 253: 45-53.
27. Jaruga P, Jaruga B, Gackowski D, et al. (2002) Supplementation with antioxidant vitamins prevents oxidative modification of DNA in lymphocytes of HIV-infected patients. Free Radic Biol Med 32 (5): 414-420.
28. Dobmeyer TS, Findhammer S, Dobmeyer JM, et al. (1997) Ex vivo induction of apoptosis in lymphocytes is mediated by oxidative stress: role for lymphocyte loss in HIV infection. Free Radic Biol Med 22 (5): 775-785.
29. Bautista AP, (2001) Free radicals, chemokines, and cell injury in HIV-1 and SIV infections and alcoholic hepatitis. Free Radical Biology and Medicine 31: 1527-1532.
30. Favier A, Sappey C, Leclerc P, Faure P, Micoud M, (1994) Antioxidant status and lipid peroxidation in patients infected with HIV. Chem Biol Interact 9: 165-180.
31. Osakwe CE, Bleotu C, Chifiriuc MC, Crancea C, Otelea D, et al. (2010) TH1/TH2 Cytokine Levels as an Indicator for Disease Progression in Human Immunodeficiency Virus Type 1 Infection and Response to Antiretroviral Therapy. Roum Arch Microbiol Immunol 69: 24-34.
32. Klein SA, Dobmeyer JM, Dobmeyer TS, Pape M, Ottmann OG, et al. (1997) Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 11: 1111-1118.
33. Said EA, Dupuy FP, Trautmann L, Zhang Y, Shi Y, et al. (2010) Programmed death-1-induced interleukin-10 production by monocytes impairs CD4+ T cell activation during HIV infection. Nat Med 16: 452-9.
34. Brockman MA, Kwon DS, Tighe DP, Pavlik DF, Rosato PC, et al. (2009) IL-10 is up-regulated in multiple cell types during viremic HIV infection and reversibly inhibits virus-specific T cells. Blood 114: 346-56.